Skip to content
Clinical Trials – home
SpainBack to Spain

Clinical trials in Burgos – page 5

88 clinical trials in Burgos, Spain across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.

SpainOur site in SpainEnsayosClinicos.es(opens in a new tab)
Burgos at a glance
88
clinical trials
  • Research sites1
Type of trial
Recruitment status
Quick filters

88 trials in Burgos

Open in trial search

Study of tarlatamab alone or with FOLFIRI chemotherapy for patients with advanced digestive system or unknown origin neuroendocrine carcinomas

Registered drugNo placebo
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Fluorouracil
  • Sponsor:Grupo Espanol De Tumores Neuroendocrinos

Study on the Safety and Immune Response of MenABCWY Vaccine and Drug Combination in Healthy Infants with Meningococcal Infections

Registered drugNo placebo
Countries:SpainSpain
  • Participants:0–17 years · Healthy volunteers
  • Substances:GSKVX000000017986
  • Sponsor:GlaxoSmithKline Biologicals

Study Comparing BMS-986365 with Other Treatments for Patients with Metastatic Castration-resistant Prostate Cancer

Registered drugNo placebo
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Abiraterone
  • Sponsor:Celgene Corp.

Asthma

Not recruiting

Study on the Effectiveness and Safety of Benralizumab with Budesonide and Formoterol in Patients with Eosinophilic Asthma Uncontrolled by Standard Treatment

Registered drug
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Benralizumab
  • Sponsor:AstraZeneca AB

Study of Quizartinib with Chemotherapy for Adults with Newly Diagnosed FLT3-ITD Negative Acute Myeloid Leukemia

Registered drug
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Cytarabine
  • Sponsor:Daiichi Sankyo Inc.

Huntington's disease

Not recruiting

Study on the Effects of Metformin on Cognitive Function in Patients with Huntington's Disease

Registered drug
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Metformin Hydrochloride
  • Sponsor:IIS La Fe

Study on Palbociclib and Endocrine Therapy for Patients with HR+/HER2- Early Breast Cancer

InvestigationalNo placebo
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Palbociclib
  • Sponsor:ABCSG GmbH

Parkinson's disease

Not recruiting

Study on the Effects and Safety of Prasinezumab for Patients with Early Parkinson's Disease

Investigational
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Prasinezumab
  • Sponsor:F. Hoffmann-La Roche AG

Cardiac failure chronic+1

Not recruiting

Study on Managing Heart Failure and Kidney Disease in Elderly Patients with High Potassium Risk Using Sodium Zirconium Cyclosilicate

Registered drugNo placebo
Countries:SpainSpain
  • Participants:65+ years
  • Substances:Sodium Zirconium Cyclosilicate
  • Sponsor:Hospital Clinico Universitario De Valencia

Study on the Long-Term Safety of Pimavanserin for Treating Irritability in Children and Adolescents with Autism Spectrum Disorder

InvestigationalNo placebo
Countries:SpainSpain
  • Participants:0–17 years
  • Substances:Pimavanserin Tartrate
  • Sponsor:Acadia Pharmaceuticals Inc.

Study on the Effectiveness of OPT-302 and Ranibizumab for Patients with Wet Age-related Macular Degeneration

Registered drugNo placebo
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Ranibizumab
  • Sponsor:Opthea Limited
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Buparlisib
  • Sponsor:Adlai Nortye USA Inc.

Other cities in Spain

The busiest research cities in the country

All 218 cities in Spain

Clinical research in Burgos

What the registry says about research in the country

01 Oncology Research

Innovative clinical trials investigating treatments for various cancers, including hepatocellular carcinoma, breast cancer, and neuroendocrine tumors. Studies focus on evaluating novel therapeutic combinations and targeted treatments.

  • HER2-positive breast cancer therapies
  • Advanced liver cancer treatments
  • Colon cancer interventions

Several trials are exploring immunotherapy combinations and precision medicine approaches for better patient outcomes.

02 Hematological Disorders

Research focusing on blood disorders including immune thrombocytopenia, acute myeloid leukemia, and mantle cell lymphoma. Studies evaluate both novel therapies and treatment combinations.

  • ITP treatment innovations
  • Leukemia interventions
  • Lymphoma therapies

Trials aim to improve treatment responses and patient outcomes in various blood disorders.

03 Neurological Conditions

Clinical research examining treatments for Huntington's Disease and Parkinson's Disease, with a focus on cognitive improvements and disease modification strategies.

  • Cognitive function studies
  • Disease-modifying therapies
  • Long-term treatment effects

Investigations include both novel compounds and repurposed medications for neurodegenerative conditions.

04 Respiratory Medicine

Studies examining treatments for respiratory syncytial virus and chronic obstructive pulmonary disease, including vaccine development and therapeutic interventions.

  • RSV vaccine trials
  • COPD management
  • Pulmonary embolism treatment

Research focuses on both preventive strategies and treatment optimization.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.